Trial Summary
What is the purpose of this trial?
The Michigan Men's Diabetes Project 2 (MenD 2) is an 18-month pilot randomized clinical trial. We are looking to recruit 60 Black men with type 2 diabetes (need to have diagnosis for at least 6 months) that are over the age of 21. Interested participants need to be under the care of a physician for their diabetes, have access to reliable transportation for study activities, and be willing to participate in 4 health assessments where they will get their A1C, blood pressure, height, and weight measured and they will complete a survey. All participants will receive 10 hours of diabetes self-management education with a Certified Diabetes Care and Education Specialist. Participants randomized to the intervention arm will also be offered 6 months of monthly diabetes self-management support (DSMS) sessions with trained Peer Leaders who are also Black men with type 2 diabetes. After the 6 months of support, this group will transition into 6 months of ongoing support where they can continue DSMS and/or other diabetes related initiatives that are important to the group and chosen by the group. Due to the COVID-19 pandemic, DSME and DSMS sessions will likely be held via Zoom, ongoing support sessions have potential to be in person. The 4 health assessments will take place at baseline, 3-months, 9-months, and 15-months.
Research Team
Jaclynn Hawkins, PhD
Principal Investigator
University of Michigan, School of Social Work
Eligibility Criteria
The Michigan Men's Diabetes Project 2 is seeking Black men over the age of 21 with type 2 diabetes diagnosed for at least six months. Participants must be under a doctor's care, have reliable transportation, and an A1c level of 8% or higher. They should be willing to attend group sessions and complete health assessments throughout the study.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Diabetes Self-Management Education (NA)
- Peer Led Diabetes Self-Management Support (NA)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
Marschall S. Runge
University of Michigan
Chief Executive Officer since 2015
MD, PhD
Karen McConnell
University of Michigan
Chief Medical Officer since 2020
MD